| Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs | Sarah de Crescenzo | 06/05/20 | Boston |
| Ventus Launches With $60M to Shine Light on Innate Immune System Drugs | Frank Vinluan | 05/06/20 | Boston |
| Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More | Sarah de Crescenzo | 01/10/20 | National |
| Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More | Sarah de Crescenzo | 12/06/19 | National |
| IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator | Frank Vinluan | 12/02/19 | Boston |
| Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More | Ben Fidler | 09/13/19 | National |
| The Winners of the 2019 Xconomy Awards Boston Are… | Jeff Bauter Engel | 09/12/19 | Boston |
| Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone | Frank Vinluan | 09/06/19 | National |
| Novartis & IFM Team Up Again, With Buyout Option for Autoimmune R&D | Frank Vinluan | 09/05/19 | Boston |
| Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre | Frank Vinluan | 04/01/19 | Boston |
| Harvard Spinout 28-7 Launches with $65M for MicroRNA Cancer Drugs | Frank Vinluan | 09/06/18 | Boston |
| New Faces, Big Impact: Meet the Finalists For Xconomy’s Newcomer Award | Ben Fidler | 08/07/18 | Boston |
| The 2018 Xconomy Awards Finalists Are… | Corie Lok | 06/28/18 | Boston |
| The Revolution in Inflammation Drug Development | Gary Glick | 05/15/18 | Boston |
| Bristol-Myers Bets Nearly $2B on Nektar for an Immunotherapy Boost | Alex Lash | 02/14/18 | New York |
| With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer | Frank Vinluan | 11/14/17 | Boston |
| Last Chance to Save on Boston’s Life Science Disruptors | Jamie Gulden | 09/20/17 | Boston |
| Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More | Ben Fidler | 09/08/17 | National |
| Catch Dragonfly, IFM, Tesaro at “Disruptors” on Sept. 28 | Ben Fidler | 09/05/17 | Boston |
| Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National |
| IFM Therapeutics Receives $27,000,000 Series A Round | VentureDeal | 06/23/16 | Boston |
| Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases | Ben Fidler | 06/22/16 | Boston |
